Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664807 · ClinicalTrials.gov registry record
Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)
A clinical trial, sponsored by Medtronic Corporate Technologies and New Ventures.
- Completed
- Registry status
- 1,023
- Enrollment target
NCT00664807 is a clinical trial that has completed, run by Medtronic Corporate Technologies and New Ventures. The registered enrollment target is 1,023 participants.
The verdict
NCT00664807 has completed, sponsored by Medtronic Corporate Technologies and New Ventures.
- COMPLETED
- Registry status
- 1,023 participants
- Enrollment target
Study Summary
To generate a list of potential genetic markers that correlate with an increased risk of life-threatening arrhythmias. To evaluate ECG-based risk markers such as heart rate variability and T-wave Alternans for their association with arrhythmic events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,023 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00664807
The ClinicalTrials.gov registry entry for NCT00664807 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,023 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Corporate Technologies and New Ventures, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00664807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00664807 about?
NCT00664807 is a clinical study titled "Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)". To generate a list of potential genetic markers that correlate with an increased risk of life-threatening arrhythmias. To evaluate ECG-based risk markers such as heart rate variability and T-wave Alternans for their association with arrhythmic events.
What is the current status of trial NCT00664807?
This trial is currently completed. The enrollment target is 1,023 participants. The study started on 2008-04. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT00664807?
This trial is sponsored by Medtronic Corporate Technologies and New Ventures, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.